Caleb is only 11 years old, but his life has already been irrevocably and tragically shaped by a genetic blood disorder. The young boy from Ghana has had a series of strokes caused by sickle cell disease. They left him unable to walk or feed himself. But now there is hope that future generations of children with sickle cell disease in Ghana might have a better chance of leading relatively normal lives. Through the legacy of a Yale-educated doctor, in partnership with the government of Ghana and Novartis, efforts are underway to screen more newborn babies for the disease, and expand the availability of care and medicine for those who inherit the disorder. Learn more: https://bit.ly/3peNz5q ©2022 Novartis AG

 16509      112